Market Overview:
The global bird flu treatment market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bird flu, rising awareness about bird flu and its prevention, and technological advancements in the field of bird flu treatment. The global bird flu treatment market can be segmented on the basis of type into antibiotics, vaccines, antiviral agents, and immunoglobulins. The antibiotics segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to factors such as increasing incidence of antibiotic-resistant strains of H5N1 virus and growing demand for effective treatments against avian influenza viruses.
Product Definition:
Bird flu treatment is the use of antiviral drugs to treat bird flu. The importance of bird flu treatment is that it can help reduce the severity of the illness and improve survival rates.
Antibiotics:
Antibiotics Market Size, Share & Trends Analysis Report By Type (Penicillin Based, Macrolides Based), By Application (Respiratory Tract Infection Treatment, Skin Abscesses Treatment) And Segment Forecasts To 2020 -> The global antibiotics market is expected to grow at a lucrative rate during the forecast period owing to increasing incidences of infectious diseases. According to the CDC statistics; every year around 25 million people in U.
Vaccines:
Vaccines are biological agents used to stimulate the body's immune system to act against a disease-causing agent. There are two types of vaccines: attenuated and inactivated. Attenuated vaccines contain active ingredients that help fight diseases like measles, mumps, and rubella (MMR).
Application Insights:
The market is segmented by application into hospitals, clinics, institutional health centers and online pharmacies. Hospitals held the largest share of over 60% in 2017. This large share can be attributed to the presence of a strong network of hospitals and veterinary authorities that are capable of handling any emergency situation that may arise during an outbreak.
Clinics are expected to witness lucrative growth over the forecast period owing to their ability to offer treatment at a lower cost as compared with hospital treatments and availability seven days a week for all flu-related conditions. The majority of bird owners prefer visiting clinics as they offer more flexibility than hospitals when it comes time for vaccination schedules or medical procedures involving poultry animals such as chickens or ducks.
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high awareness levels coupled with relatively higher health expenditure are some factors responsible for its large share. Moreover, increasing incidence of highly contagious COVID-19 pandemic across this region is expected to boost product demand during the forecast period.
Asia Pacific is estimated to be the fastest growing regional market over the forecast period owing to rising prevalence of infectious diseases and lack of proper hygiene & sanitation in many countries including India, China and Indonesia among others. In addition, rapidly developing economy and expanding medical tourism industry are also contributing towards growth in this region.
Growth Factors:
- Increasing awareness about bird flu and the need for timely treatment.
- Growing number of cases of bird flu outbreaks in different parts of the world.
- Development of new and more effective treatments for bird flu infections.
- Increased funding for research on new treatments for bird flu infections.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bird Flu Treatment Market Research Report
By Type
Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
By Application
Hospitals, Clinics, Institutional Health Centers, Online Pharmacies
By Companies
Sanofi, Roche, GlaxoSmithKline, Pfizer, Cipla, Abbott, BioCryst Pharmaceuticals, Forrest Pharmaceuticals, Gilead Sciences, Macleods Pharmaceuticals, Sinovac Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Bird Flu Treatment Market Report Segments:
The global Bird Flu Treatment market is segmented on the basis of:
Types
Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Institutional Health Centers, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Roche
- GlaxoSmithKline
- Pfizer
- Cipla
- Abbott
- BioCryst Pharmaceuticals
- Forrest Pharmaceuticals
- Gilead Sciences
- Macleods Pharmaceuticals
- Sinovac Biotech
Highlights of The Bird Flu Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Vaccines
- Antiviral Agents
- Immunoglobulins
- By Application:
- Hospitals
- Clinics
- Institutional Health Centers
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bird Flu Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for bird flu, but people who are infected with the virus may need to take antiviral medication to reduce the severity of their symptoms. People who are severely ill with bird flu may need hospitalization.
Some of the major companies in the bird flu treatment market are Sanofi, Roche, GlaxoSmithKline, Pfizer, Cipla, Abbott, BioCryst Pharmaceuticals, Forrest Pharmaceuticals, Gilead Sciences, Macleods Pharmaceuticals, Sinovac Biotech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bird Flu Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bird Flu Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bird Flu Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bird Flu Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bird Flu Treatment Market Size & Forecast, 2020-2028
4.5.1 Bird Flu Treatment Market Size and Y-o-Y Growth
4.5.2 Bird Flu Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Vaccines
5.2.3 Antiviral Agents
5.2.4 Immunoglobulins
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Institutional Health Centers
6.2.4 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bird Flu Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bird Flu Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Vaccines
9.6.3 Antiviral Agents
9.6.4 Immunoglobulins
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Institutional Health Centers
9.10.4 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Vaccines
10.6.3 Antiviral Agents
10.6.4 Immunoglobulins
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Institutional Health Centers
10.10.4 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Vaccines
11.6.3 Antiviral Agents
11.6.4 Immunoglobulins
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Institutional Health Centers
11.10.4 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Vaccines
12.6.3 Antiviral Agents
12.6.4 Immunoglobulins
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Institutional Health Centers
12.10.4 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Vaccines
13.6.3 Antiviral Agents
13.6.4 Immunoglobulins
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Institutional Health Centers
13.10.4 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bird Flu Treatment Market: Competitive Dashboard
14.2 Global Bird Flu Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Roche
14.3.3 GlaxoSmithKline
14.3.4 Pfizer
14.3.5 Cipla
14.3.6 Abbott
14.3.7 BioCryst Pharmaceuticals
14.3.8 Forrest Pharmaceuticals
14.3.9 Gilead Sciences
14.3.10 Macleods Pharmaceuticals
14.3.11 Sinovac Biotech
